Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120401

Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.

Antimicrobial agents and chemotherapy 20120301

Design, synthesis of some new (2-aminothiazol-4-yl)methylester derivatives as possible antimicrobial and antitubercular agents.

European journal of medicinal chemistry 20120301

Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes.

Anais brasileiros de dermatologia 20120101

Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.

Cancer research 20111215

Recurrent vulvovaginal candidosis: focus on the vulva.

Mycoses 20111101

Standardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamine.

Mycopathologia 20111001

Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling.

American journal of physiology. Cell physiology 20111001

Tinea capitis in an adult patient under treatment with trastuzumab.

Mycoses 20110901

In vivo efficacy of griseofulvin against multiple myeloma.

Leukemia research 20110801

Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.

The British journal of dermatology 20110701

The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway.

Oncogene 20110505

Multipotent adult germline stem cells and embryonic stem cells functional proteomics revealed an important role of eukaryotic initiation factor 5A (Eif5a) in stem cell differentiation.

Journal of proteome research 20110401

The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.

Journal of clinical pharmacy and therapeutics 20110401

Determination of ciclopirox olamine in pharmaceutical products by capillary electrophoresis with capacitively coupled contactless conductivity detection.

Electrophoresis 20110401

Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.

Transplant infectious disease : an official journal of the Transplantation Society 20110201

Microsporum praecox: molecular identification of a new case and review of the literature.

Mycopathologia 20110101

Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.

In vivo (Athens, Greece) 20110101

Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing.

PloS one 20110101

The antitumor activity of the fungicide ciclopirox.

International journal of cancer 20101115

Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Drugs 20101112

Widespread erosive tinea corporis by Arthroderma benhamiae in a renal transplant recipient: case report.

Mycoses 20101101

First case of Trichophyton soudanense isolated in Tunisia.

Mycopathologia 20101101

Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives.

European journal of medicinal chemistry 20101101

Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Bioorganic & medicinal chemistry letters 20101101

Ciclopirox olamine: an antifungal alternative against cryptococcosis.

Letters in applied microbiology 20101101

Design, synthesis and antimicrobial activities of some new quinoline derivatives carrying 1,2,3-triazole moiety.

European journal of medicinal chemistry 20100901

Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.

Drug development and industrial pharmacy 20100801

Hypoxia-inducible factor-1 improves inotropic responses of cardiac myocytes in ageing heart without affecting mitochondrial activity.

Experimental physiology 20100601

Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.

The Journal of pharmacy and pharmacology 20100601

Antifungal activity, experimental infections and nail permeation of an innovative ciclopirox nail lacquer based on a water-soluble biopolymer.

Journal of drugs in dermatology : JDD 20100501

[Melanonychia: The purpose of a case of ungual mycotization mimicking melanoma].

Dermatology online journal 20100315

Onychomycosis.

Clinics in dermatology 20100304

Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles.

European journal of medicinal chemistry 20100301

Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.

The British journal of dermatology 20100201

Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.

The Journal of dermatology 20100201

A direct LC/MS/MS method for the determination of ciclopirox penetration across human nail plate in in vitro penetration studies.

Journal of pharmaceutical and biomedical analysis 20100105

A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children.

Pediatric dermatology 20100101

Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis.

Journal of cosmetic dermatology 20091201

Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.

Medical mycology 20091101

The human urocortin 2 gene is regulated by hypoxia: identification of a hypoxia-responsive element in the 3'-flanking region.

The Biochemical journal 20091023

Iontophoretically enhanced ciclopirox delivery into and across human nail plate.

Journal of pharmaceutical sciences 20091001

Onychomycosis and diabetes.

Journal of the European Academy of Dermatology and Venereology : JEADV 20091001

Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.

Blood 20091001

By the way, doctor. Penlac didn't work to cure my toenail fungus. I took an oral medication, terbinafine, and saw some improvement, but my insurance company won't approve more than a few months of treatment. It's frustrating to finally have a solution and then be cut off.

Harvard health letter 20091001

Hypoxia inducible factor-1 improves the actions of positive inotropic agents in stunned cardiac myocytes.

Clinical and experimental pharmacology & physiology 20090901

Bullous ulcerating tinea.

Journal of the European Academy of Dermatology and Venereology : JEADV 20090701

An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.

Journal of the European Academy of Dermatology and Venereology : JEADV 20090701

The use of oral terbinafine or topical ciclopirox for lichen planus.

Cutis 20090701

Clinical practice. Fungal nail disease.

The New England journal of medicine 20090514

Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells.

Neurotoxicity research 20090501

Targeting Wnt pathway in lymphoma and myeloma cells.

British journal of haematology 20090301

Synthesis and antimicrobial activities of some new triazolothiadiazoles bearing 4-methylthiobenzyl moiety.

European journal of medicinal chemistry 20090201

Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.

Mycoses 20090101

Nail infection by Aspergillus ochraceopetaliformis.

Medical mycology 20090101

Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial.

The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 20090101

Toenail onychomycosis in diabetic patients: issues and management.

American journal of clinical dermatology 20090101

Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Retrovirology 20090101

Evaluation of a nonsteroidal topical cream in a guinea pig model of Malassezia furfur infection.

Clinics in dermatology 20090101

Onychomycosis in a very young child.

Pediatric dermatology 20090101

Ototoxic effect of topical ciclopirox as an antimycotic preparation.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20081001

Antimicrobial activity of iodoquinol 1%-hydrocortisone acetate 2% gel against ciclopirox and clotrimazole.

Cutis 20081001

Fast and simple method for assay of ciclopirox olamine by micellar electrokinetic capillary chromatography.

Journal of pharmaceutical and biomedical analysis 20080805

In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.

Journal of chemotherapy (Florence, Italy) 20080801

Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.

Mycoses 20080701

Contact allergy to topical antifungal agents.

Allergy 20080701

Synthesis, antimicrobial and anti-inflammatory activities of some 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines bearing trichlorophenyl moiety.

European journal of medicinal chemistry 20080401

Synthesis of some novel 2,4-disubstituted thiazoles as possible antimicrobial agents.

European journal of medicinal chemistry 20080201

In search of novel agents for therapy of tropical diseases and human immunodeficiency virus.

Journal of medicinal chemistry 20080124

Ciclopirox olamine directly scavenges hydroxyl radical.

International journal of dermatology 20080101

Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus.

Acta dermato-venereologica 20080101

Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity.

Pharmacology 20080101

In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate.

Journal of pharmaceutical sciences 20071001

[Mucoadhesive tablets for oral administration of ciclopiroxolamine].

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20071001

Convenient one pot synthesis and antimicrobial evaluation of some new Mannich bases carrying 4-methylthiobenzyl moiety.

European journal of medicinal chemistry 20070801

Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.

Mycopathologia 20070701

Trichophytic Majocchi granuloma mimicking Kaposi sarcoma.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20070701

An atypical active cell death process underlies the fungicidal activity of ciclopirox olamine against the yeast Saccharomyces cerevisiae.

FEMS yeast research 20070501

Inhibitory or scavenging action of ketoconazole and ciclopiroxolamine against reactive oxygen species released by primed inflammatory cells.

The British journal of dermatology 20070401

Toenail onychomycosis: current and future treatment options.

Dermatologic therapy 20070101

Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study.

Journal of the American Podiatric Medical Association 20070101

Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.

The Journal of dermatological treatment 20070101

An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.

Indian journal of dermatology, venereology and leprology 20070101

Malassezia furfur onychomycosis in an immunosuppressed liver transplant recipient.

Indian journal of dermatology, venereology and leprology 20070101

In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.

Mycopathologia 20061201

Majocchi's granuloma after kidney transplantation.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20061201

[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].

Revista iberoamericana de micologia 20061201

Spectrofluorimetric determination of ciclopirox olamine via ternary complex with Tb(III) and EDTA.

Acta pharmaceutica (Zagreb, Croatia) 20061201

Piperidones with activity against Plasmodium falciparum.

Parasitology research 20060801

Dystrophic onychomycosis due to Microsporum gypseum.

Mycoses 20060701

Contact dermatitis due to ciclopiroxolamine.

Mycoses 20060701

Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails.

Die Pharmazie 20060701

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Antimycotic influence of beta-cyclodextrin complexes--in vitro measurements using laser nephelometry in microtiter plates.

International journal of pharmaceutics 20060327

Congenital candidal onychomycoses: effective cure with ciclopirox olamine 8% nail lacquer.

The British journal of dermatology 20060301

Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.

International journal of dermatology 20060101

Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study.

Skin pharmacology and physiology 20060101

Rapid treatment of tinea nigra palmaris with ciclopirox olamine gel, 0.77%.

Skinmed 20060101

Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment.

European journal of dermatology : EJD 20060101

A-Detail fact sheet (Canada). Ciclopirox 8% nail lacquer (Penlac).

Skin therapy letter 20051201

Ciclopirox nail lacquer 8% for the treatment of onychomycosis: a Canadian perspective.

Skin therapy letter 20050901

Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.

International journal of dermatology 20050701

Ciclopirox protects mitochondria from hydrogen peroxide toxicity.

British journal of pharmacology 20050601

Can the use of a topical antifungal nail lacquer reduce risk for diabetic foot ulceration? Results from a randomised controlled pilot study.

International wound journal 20050601

Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.

The Journal of antimicrobial chemotherapy 20050501

Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans.

The Journal of antimicrobial chemotherapy 20050501

The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis.

Expert opinion on drug safety 20050301

Physicochemical studies on Ciclopirox olamine complexes with divalent metal ions.

International journal of pharmaceutics 20050131

Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV 20050101

Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.

Archives of dermatology 20050101

A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans.

Journal of drugs in dermatology : JDD 20050101

In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer.

Drug development and industrial pharmacy 20050101

Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study.

Journal of drugs in dermatology : JDD 20050101

Treatment costs of three nail lacquers used in onychomycosis.

The Journal of dermatological treatment 20050101

Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.

The Journal of dermatological treatment 20050101

Cutaneous adiaspiromycosis: a distinct dermatologic entity associated with Chrysosporium species.

Journal of the American Academy of Dermatology 20041101

Ciclopirox delivery into the human nail plate.

Journal of pharmaceutical sciences 20041001

Management of onychomycosis with topicals.

Clinics in podiatric medicine and surgery 20041001

Cell cycle arrest at the initiation step of human chromosomal DNA replication causes DNA damage.

Journal of cell science 20041001

Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties.

International journal of dermatology 20040701

Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.

International journal of dermatology 20040701

Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.

International journal of dermatology 20040701

Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.

International journal of dermatology 20040701

Activation of HIF-1alpha mRNA by hypoxia and iron chelator in isolated rat carotid body.

Neuroscience letters 20040617

Tinea capitis favosa in Poland.

Mycoses 20040601

The use of 40% urea cream in the treatment of moccasin tinea pedis.

Cutis 20040501

[Onychomycosis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20040201

Fungus-free versus disease-free nails.

Journal of the American Academy of Dermatology 20040101

Dermacase. Pityriasis rosea.

Canadian family physician Medecin de famille canadien 20040101

Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen.

Cutis 20040101

Assessing treatment outcomes in toenail onychomycosis clinical trials.

American journal of clinical dermatology 20040101

Ciclopirox (Loprox) gel for superficial fungal infections.

Skin therapy letter 20040101

Ciclopirox shampoo for treating seborrheic dermatitis.

Skin therapy letter 20040101

A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.

International journal of tissue reactions 20040101

Polarographic determination of ciclopirox olamine in pure substance and in different pharmaceutical preparations.

Farmaco (Societa chimica italiana : 1989) 20031201

Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis.

Mycoses 20031201

Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea.

The Journal of dermatological treatment 20031201

Permeation of ciclopirox across porcine hoof membrane: effect of pressure sensitive adhesives and vehicles.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20031101

Effects of hypoxia and intracellular iron chelation on hypoxia-inducible factor-1alpha and -1beta in the rat carotid body and glomus cells.

Histochemistry and cell biology 20031101

I've heard there's a nail polish for nail fungus. Does it work?

Mayo Clinic women's healthsource 20031001

Ciclopirox gel: an update.